These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8943493)

  • 1. Effect of serum subfractions from peritoneal dialysis patients on Hep-G2 cell apolipoprotein A-I and B metabolism.
    Shah GM; Lin ZL; Kamanna VS; Pai R; Bassa B; Jin FY; Roh DD; Kashyap ML; Kirschenbaum MA
    Kidney Int; 1996 Dec; 50(6):2079-87. PubMed ID: 8943493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uremic serum subfraction inhibits apolipoprotein A-I production by a human hepatoma cell line.
    Kamanna VS; Kashyap ML; Pai R; Bui DT; Jin FY; Roh DD; Shah GM; Kirschenbaum MA
    J Am Soc Nephrol; 1994 Aug; 5(2):193-200. PubMed ID: 7993998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 25-hydroxycholesterol and bile acids on the regulation of cholesterol metabolism in Hep G2 cells.
    Carlson TL; Kottke BA
    Biochem J; 1989 Nov; 264(1):241-7. PubMed ID: 2513806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2).
    Arrol S; Mackness MI; Durrington PN
    Atherosclerosis; 2000 Jun; 150(2):255-64. PubMed ID: 10856517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of HMG-CoA reductase inhibitor (CS-514) on the synthesis and secretion of apolipoproteins B and A-1 in the human hepatoblastoma Hep G2.
    Sato R; Imanaka T; Takano T
    Biochim Biophys Acta; 1990 Jan; 1042(1):36-41. PubMed ID: 2153411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin inhibits apolipoprotein AI and AII production in human hepatoblastoma cell line (Hep G2): additive effects of oleate-albumin complex.
    Sakai T; Jin FY; Kamanna VS; Kashyap ML
    Atherosclerosis; 2000 Mar; 149(1):43-9. PubMed ID: 10704613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production.
    Moradi H; Said HM; Vaziri ND
    Transl Res; 2013 Jun; 161(6):477-85. PubMed ID: 23219399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein synthesis and secretion in Hep G2 cells: effects of monensin and cycloheximide.
    Hahn SE; Parkes JG; Goldberg DM
    Biochem Cell Biol; 1992 Dec; 70(12):1339-46. PubMed ID: 1338570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal survey of apolipoproteins and atherogenic risk in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Burrell D; Antignani A; Fein PA; Goldwasser P; Mittman N; Avram MM
    ASAIO Trans; 1990; 36(3):M331-5. PubMed ID: 2123635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.
    Qin S; Koga T; Ganji SH; Kamanna VS; Kashyap ML
    Metabolism; 2008 Jul; 57(7):973-9. PubMed ID: 18555840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butyrate stimulates the secretion of apolipoprotein (apo) A-I and apo B100 by the human hepatoma cell line Hep G2. Induction of apo A-I mRNA with no change of apo B100 mRNA.
    Kaptein A; Roodenburg L; Princen HM
    Biochem J; 1991 Sep; 278 ( Pt 2)(Pt 2):557-64. PubMed ID: 1654887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of lipoprotein production in Hep G2 cells by fenofibrate and clofibrate.
    Hahn SE; Goldberg DM
    Biochem Pharmacol; 1992 Feb; 43(3):625-33. PubMed ID: 1311585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone increases apolipoprotein A-I concentrations in medium and apolipoprotein A-I mRNA abundance from Hep G2 cells.
    Varma VK; Smith TK; Sorci-Thomas M; Ettinger WH
    Metabolism; 1992 Oct; 41(10):1075-80. PubMed ID: 1328818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, decreases apolipoprotein B-100 secretion from Hep G2 cells.
    Ooyen C; Zecca A; Bersino AM; Catapano AL
    Atherosclerosis; 1999 Jul; 145(1):87-95. PubMed ID: 10428299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular apoprotein B degradation is suppressed by decreased albumin concentration in Hep G2 cells.
    Hirano T; Furukawa S; Kurokawa M; Ebara T; Dixon JL; Nagano S
    Kidney Int; 1995 Feb; 47(2):421-31. PubMed ID: 7536855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin.
    Byrne CD; Wang TW; Hales CN
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):101-7. PubMed ID: 1332692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: the role of postheparin lipases in the metabolism of high-density lipoprotein subfractions.
    Chan MK
    Metabolism; 1989 Oct; 38(10):939-45. PubMed ID: 2507877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar to oleic acid, eicosapentaenoic acid stimulates apolipoprotein B secretion by inhibiting its intracellular degradation in Hep G2 cells.
    Kurokawa M; Hirano T; Furukawa S; Nagano S; Adachi M
    Atherosclerosis; 1995 Jan; 112(1):59-68. PubMed ID: 7772067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.